Literature DB >> 11803076

Frequency and causes of vaccine wastage.

Sabeena Setia1, Hugh Mainzer, Michael L Washington, Gary Coil, Robert Snyder, Bruce G Weniger.   

Abstract

UNLABELLED: Assessing the frequency of vaccine wastage and the relative magnitude of its various causes may help to target efforts to reduce these losses and to husband funds for increasingly expensive vaccines.
METHODS: As a preliminary overview of wastage in the United States, 64 public-sector state and local health department immunization programs were polled in 1998 and 1999 for wastage recording practices. Actual wastage data were collected from a non-random subset of five states. Data on returns of wasted vaccine to manufacturers were analyzed from routine national biologics surveillance and from an ad-hoc survey. Excise tax credit requests for such returns between 1994 and 1999 were reviewed.
RESULTS: Rates of wastage among the five states ranged from about 1 to 5% in 1998, with an overall rate of 2.6% among 57 immunization programs in 1999. Categories of wastage used by the health departments varied widely, with overlapping classifications. The major causes appeared to be refrigeration (cold chain) lapses, followed by expiration. Overall rates of vaccine returns varied up to 8% by manufacturer, and from 1 to 50% by vaccine type, with higher return rates generally found for lesser-used vaccines.
CONCLUSIONS: If these wastage estimates of 1-5% applied nationally, in 1998 there would have been approximately US dollars 6-31 million worth of unused vaccine in the public sector alone. The two most common forms of wastage reveal the potential value of developing vaccines with improved heat stability and longer shelf lives. We propose six main classifications of vaccine wastage for use in routine monitoring and reporting.

Mesh:

Substances:

Year:  2002        PMID: 11803076     DOI: 10.1016/s0264-410x(01)00433-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  A web-based tool for designing vaccine formularies for childhood immunization in the United States.

Authors:  Sheldon H Jacobson; Edward C Sewell
Journal:  J Am Med Inform Assoc       Date:  2008-06-25       Impact factor: 4.497

2.  Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes.

Authors:  Osman David Mansoor; Debra Kristensen; Andrew Meek; Simona Zipursky; Olga Popova; Olga Popovaa; InderJit Sharma; Gisele Miranda; Jules Millogo; Heidi Lasher
Journal:  Bull World Health Organ       Date:  2012-11-05       Impact factor: 9.408

3.  Evaluation of non-continuous temperature monitoring practices for vaccine storage units: A Monte Carlo simulation study.

Authors:  Andrew J Leidner; Carla E Lee; Ashley Tippins; Mark L Messonnier; John M Stevenson
Journal:  J Public Health (Bangkok)       Date:  2020-03-22

4.  Shipping and Logistics Considerations for Regenerative Medicine Therapies.

Authors:  Tracy Criswell; Corné Swart; Jana Stoudemire; Kelvin Brockbank; Michael Floren; Shannon Eaker; Joshua Hunsberger
Journal:  Stem Cells Transl Med       Date:  2022-03-17       Impact factor: 7.655

5.  Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness analysis.

Authors:  Bo-Hyun Cho; Anna M Acosta; Andrew J Leidner; Amanda E Faulkner; Fangjun Zhou
Journal:  Prev Med       Date:  2020-03-19       Impact factor: 4.018

6.  Evaluation of temperature stability among different types and grades of vaccine storage units: Data from continuous temperature monitoring devices.

Authors:  Andrew J Leidner; Helen Fisun; Sean Trimble; Paul Lucas; Cameron Noblit; John M Stevenson
Journal:  Vaccine       Date:  2020-02-25       Impact factor: 3.641

7.  Provider Attitudes Regarding Vaccine Tracking Systems in Pediatric Practices.

Authors:  Sean T O'Leary; Laura P Hurley; Erin D Kennedy; Lori A Crane; Michaela Brtnikova; Mandy A Allison; Warren Williams; Brenda L Beaty; Andrea Jimenez-Zambrano; Allison Kempe
Journal:  Acad Pediatr       Date:  2015-10-29       Impact factor: 3.107

8.  Maintaining vaccine delivery following the introduction of the rotavirus and pneumococcal vaccines in Thailand.

Authors:  Bruce Y Lee; Tina-Marie Assi; Korngamon Rookkapan; Angela R Wateska; Jayant Rajgopal; Vorasith Sornsrivichai; Sheng-I Chen; Shawn T Brown; Joel Welling; Bryan A Norman; Diana L Connor; Rachel R Bailey; Anirban Jana; Willem G Van Panhuis; Donald S Burke
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

9.  Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs.

Authors:  Radboud J Duintjer Tebbens; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2015-09-24       Impact factor: 3.090

10.  Quantifying clinical HPV4 dose inefficiencies in a safety net population.

Authors:  Diane M Harper; Inge Verdenius; Felicia Ratnaraj; Anne M Arey; Beth Rosemergey; Gerard J Malnar; Jeffrey Wall
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.